Although patients in the high MMP score group had more CD8+ T lymphocytes in their tumor microenvironment, due to the presence of immune dysfunction and rejection, the number of immune cells that are actually effective in eliminating tumor cells is greatly reduced, thus affecting the prognosis of GC. The gene discussed is CD8A; the disease is gastric cancer.